Skip to main content
Erschienen in: Forensic Science, Medicine and Pathology 1/2013

01.03.2013 | Case Report

Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation

verfasst von: Jineane V. Venci, Meghan M. Rowcliffe, Lance Wollenberg, Michelle M. Rainka, Fran M. Gengo

Erschienen in: Forensic Science, Medicine and Pathology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The antiepileptic, carbamazepine, is extensively metabolized via hepatic enzymes in the cytochrome P450 family and is therefore subject to a myriad of drug interactions. Concomitant administration with phenytoin enhances carbamazepine metabolism thus reducing serum concentrations and necessitating the use of a higher maintenance dose. Removal of phenytoin therapy in the absence of anticipatory dose adjustments and careful monitoring of serum concentrations may result in catastrophic outcomes. Reported herein are the events leading to the death of a 23-month old child who suffered a fatal carbamazepine overdose following withdrawal of phenytoin therapy.
Literatur
1.
Zurück zum Zitat Product Information: TEGRETOL(R) chewable oral tablets, oral tablets, oral suspension, TEGRETOL(R) XR extended-release oral tablets, carbamazepine chewable oral tablets, oral tablets, oral suspension, extended-release oral tablets. In: Corporation NP, editor. East Hanover, NJ; 2003. Product Information: TEGRETOL(R) chewable oral tablets, oral tablets, oral suspension, TEGRETOL(R) XR extended-release oral tablets, carbamazepine chewable oral tablets, oral tablets, oral suspension, extended-release oral tablets. In: Corporation NP, editor. East Hanover, NJ; 2003.
2.
Zurück zum Zitat Product Information: EQUETRO(TM) oral extended release capsules, carbamazepine oral extended release capsules. In: Inc SU, editor. Wayne, PA; 2004. Product Information: EQUETRO(TM) oral extended release capsules, carbamazepine oral extended release capsules. In: Inc SU, editor. Wayne, PA; 2004.
3.
Zurück zum Zitat Me W. Carbamazepine. In: Koda-Kimble MA, editor. Basic clinical pharmacokentics. 3rd ed. Vancouver: Applied Therapeutics; 1994. p. 177–84. Me W. Carbamazepine. In: Koda-Kimble MA, editor. Basic clinical pharmacokentics. 3rd ed. Vancouver: Applied Therapeutics; 1994. p. 177–84.
4.
Zurück zum Zitat Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry. 1995;28(6):235–44.PubMedCrossRef Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry. 1995;28(6):235–44.PubMedCrossRef
5.
Zurück zum Zitat Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 1995;29(4):257–86.PubMedCrossRef Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 1995;29(4):257–86.PubMedCrossRef
6.
Zurück zum Zitat Chapron DJ, LaPierre BA, Abou-Elkair M. Unmasking the significant enzyme inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal. Ann Pharmacother. 1993;27:708–11.PubMed Chapron DJ, LaPierre BA, Abou-Elkair M. Unmasking the significant enzyme inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal. Ann Pharmacother. 1993;27:708–11.PubMed
7.
Zurück zum Zitat Duncan JS, Patsalos PN, Shorvon SD. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication. Epilepsia. 1991;31(1):101–15.CrossRef Duncan JS, Patsalos PN, Shorvon SD. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication. Epilepsia. 1991;31(1):101–15.CrossRef
8.
Zurück zum Zitat Riva R, Albani F, Contin M, Baruzzi A. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet. 1996;31(6):470–93.PubMedCrossRef Riva R, Albani F, Contin M, Baruzzi A. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet. 1996;31(6):470–93.PubMedCrossRef
9.
Zurück zum Zitat Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic interactions with carbamazepine. An update. Clin Pharmacokinet. 1996;31(3):198–214.PubMedCrossRef Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic interactions with carbamazepine. An update. Clin Pharmacokinet. 1996;31(3):198–214.PubMedCrossRef
10.
Zurück zum Zitat Zielinski JJ, Haidukewych D. Duel effects of carbamazepine-phenytoin interaction. Ther Drug Monit. 1987;9:21–3.PubMedCrossRef Zielinski JJ, Haidukewych D. Duel effects of carbamazepine-phenytoin interaction. Ther Drug Monit. 1987;9:21–3.PubMedCrossRef
11.
Zurück zum Zitat D’Argenio DZ, Schumitzky A, Wang X. ADAPT 5 user’s guide: pharmacokinetic/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource; 2009. D’Argenio DZ, Schumitzky A, Wang X. ADAPT 5 user’s guide: pharmacokinetic/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource; 2009.
12.
Zurück zum Zitat Bondareva IB, Sokolov AV, Tischenkova IF, Jelliffe RW. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage. J Clin Pharm Ther. 2001;26(3):213–23.PubMedCrossRef Bondareva IB, Sokolov AV, Tischenkova IF, Jelliffe RW. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage. J Clin Pharm Ther. 2001;26(3):213–23.PubMedCrossRef
13.
Zurück zum Zitat Faigle JW, Feldmann FK. Carbamazepine: biotransformation. In: Woodbury DM, Pippenger CE, editors. Antiepileptic drugs. New York: Raven Press; 1982. p. 483–95. Faigle JW, Feldmann FK. Carbamazepine: biotransformation. In: Woodbury DM, Pippenger CE, editors. Antiepileptic drugs. New York: Raven Press; 1982. p. 483–95.
14.
Zurück zum Zitat Bonneton J, Genton P, Mesdjian E. Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients. Biopharm Drug Dispos. 1992;13(6):411–6.PubMedCrossRef Bonneton J, Genton P, Mesdjian E. Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients. Biopharm Drug Dispos. 1992;13(6):411–6.PubMedCrossRef
15.
Zurück zum Zitat May T, Jurgens U, Rambeck B, Schnabel R. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10, 11-epoxide metabolite in institutionalized patients with epilepsy. Epilepsy Res. 1999;33(1):57–65.PubMedCrossRef May T, Jurgens U, Rambeck B, Schnabel R. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10, 11-epoxide metabolite in institutionalized patients with epilepsy. Epilepsy Res. 1999;33(1):57–65.PubMedCrossRef
16.
Zurück zum Zitat Spiller HA, Carlisle RD. Timely antemortem and postmortem concentrations in a fatal carbamazepine overdose. J Forensic Sci. 2001;46(6):1510–2.PubMed Spiller HA, Carlisle RD. Timely antemortem and postmortem concentrations in a fatal carbamazepine overdose. J Forensic Sci. 2001;46(6):1510–2.PubMed
17.
Zurück zum Zitat Han E, Kim E, Hong H, Jeong S, Kim J, In S, et al. Evaluation of postmortem redistribution phenomena for commonly encountered drugs. Forensic Sci Int. 2012;219:265–71.PubMedCrossRef Han E, Kim E, Hong H, Jeong S, Kim J, In S, et al. Evaluation of postmortem redistribution phenomena for commonly encountered drugs. Forensic Sci Int. 2012;219:265–71.PubMedCrossRef
18.
Zurück zum Zitat Spiller HA, Krenzelok EP. Carbamazepine overdose: serum concentration less predictive in children. J Toxicol Clin Toxicol. 1993;31(3):459–60.PubMedCrossRef Spiller HA, Krenzelok EP. Carbamazepine overdose: serum concentration less predictive in children. J Toxicol Clin Toxicol. 1993;31(3):459–60.PubMedCrossRef
19.
Zurück zum Zitat Spiller HA, Krenzelok EP, Cookson E. Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol. 1990;28(4):445–58.PubMedCrossRef Spiller HA, Krenzelok EP, Cookson E. Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol. 1990;28(4):445–58.PubMedCrossRef
20.
Zurück zum Zitat Tibballs J. Acute toxic reaction to carbamazepine: clinical effects and serum concentrations. J Pediat. 1992;121(2):295–9.PubMedCrossRef Tibballs J. Acute toxic reaction to carbamazepine: clinical effects and serum concentrations. J Pediat. 1992;121(2):295–9.PubMedCrossRef
21.
Zurück zum Zitat Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbamazepine intoxication. Ann Emerg Med. 1995;25(5):624–30.PubMedCrossRef Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbamazepine intoxication. Ann Emerg Med. 1995;25(5):624–30.PubMedCrossRef
Metadaten
Titel
Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation
verfasst von
Jineane V. Venci
Meghan M. Rowcliffe
Lance Wollenberg
Michelle M. Rainka
Fran M. Gengo
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Forensic Science, Medicine and Pathology / Ausgabe 1/2013
Print ISSN: 1547-769X
Elektronische ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-012-9373-7

Weitere Artikel der Ausgabe 1/2013

Forensic Science, Medicine and Pathology 1/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …